Karyopharm Therapeutics reported $22.6M in Sales Revenues for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbott ABT:US $ 10928M 705M
Abbvie ABBV:US $ 13959M 949M
Acceleron Pharma XLRN:US $ 27.94M 3.18M
Amgen AMGN:US $ 6526M 625M
AstraZeneca AZN:LN 8220M 900M
Astrazeneca AZN:US $ 8220M 900M
Biocryst Pharmaceuticals BCRX:US $ 49.96M 30.9M
Bristol Myers Squibb BMY:US $ 11703M 630M
Eli Lilly And LLY:US $ 6740.1M 65.5M
Enanta Pharmaceuticals ENTA:US $ 21.62M 1.49M
Epizyme EPZM:US $ 13.01M 5.38M
GlaxoSmithKline GSK:LN 8092M 674M
Johnson & Johnson JNJ:US $ 23338M 26M
Karyopharm Therapeutics KPTI:US $ 22.6M 659K
Macrogenics MGNX:US $ 30.76M 13.88M
Merk MRK:US $ 11402M 678M
Mirati Therapeutics MRTX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 28.33M 4.68M
Novartis NOVN:VX SF 13294M 600M
Novartis NVS:US $ 13294M 600M
Pfizer PFE:US $ 18977M 4395M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Sangamo Biosciences SGMO:US $ 27.87M 1.59M
Takeda 4502:JP Y 949603M 179329M
Tg Therapeutics TGTX:US $ 1.54M 0.75M
Ultragenyx Pharmaceutical RARE:US $ 86.98M 12.42M
Xencor XNCR:US $ 67.45M 33.48M
YTE INCY:US $ 705.71M 100.99M